Dorian Therapeutics
New therapeutics to rejuvenate tissue and treat age-related diseases
Y CombinatorSummer 2018AcquiredHealthcareTherapeuticsAnti-AgingBiotechTherapeutics
What they do
Problem
Age-related tissue degeneration and diseases lack effective rejuvenation treatments.
Solution
Develops therapeutics that rejuvenate tissue to treat age-related diseases.
Who it's for
Pharmaceutical companies and healthcare providers treating patients with age-related conditions.
Founders
Maddalena Adorno
Founder
Benedetta di Robilant
Founder
Company timeline
- Founded2018
- YC batchSummer 2018
- StatusAcquired
- Team size8 people
- LocationSan Carlos, CA, USA
Similar startups
Third Arc Bio
Clinical-stage multispecific antibody engineering platform for best-i…
Ventus Therapeutics
Structural bio platform to discover small molecules against hard-to-d…
Gilgamesh Pharmaceuticals
Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company…
ROME Therapeutics
Rome Therapeutics is developing novel therapies for cancer and autoim…
Santa Ana Bio
Developing engineered antibody therapies for selective targeting and…
Valink Therapeutics
Discovering bispecific antibody drug-conjugates (BsADC) against cancer